Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer (Q47185122)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 February 2014

Language	Label	Description	Also known as
English	Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer	scientific article published on 5 February 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

author name string

Ye Won Jeon

1

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

Seung Taek Lim

2

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

Hyun Joo Choi

3

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

Young Jin Suh

4

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

publication date

5 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

31

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

3

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

849

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

Weight gain in women diagnosed with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women's healthy eating and living (WHEL) study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight gain with breast cancer adjuvant treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight, weight gain, and survival after breast cancer diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Obesity and weight change in relation to breast cancer survival.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight change and survival after breast cancer in the after breast cancer pooling project

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Docetaxel for the adjuvant treatment of early node-positive breast cancer: a single technology appraisal

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC).

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight changes after adjuvant treatment in Korean women with early breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight gain during adjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Docetaxel-related side effects and their management

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Energy Balance in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0849-Z

21 January 2018

Effect of obesity on prognosis after early-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24496561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24496561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24496561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24496561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight gain in early-stage breast cancer: where do we go from here?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24496561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24496561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-014-0849-Z

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 January 2018

http://europepmc.org/abstract/MED/24496561

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47185122&oldid=2208456967"